| |
| |
|
| Insider
Information: |
Manhard Kimberly |
| Relationship: |
EVP, Drug Development |
| City: |
Lafayette |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
28,330 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$97,739 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
28,330 |
|
|
| Total
Value |
$97,739 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardea Biosciences Inc |
RDEA |
SVP, Regulatory & Dev ... |
2012-06-19 |
0 |
2009-05-19 |
0 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
EVP, Drug Development |
2023-04-13 |
28,330 |
2015-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2010-04-28 |
4 |
AS |
$25.16 |
$62,912 |
D/D |
(2,500) |
7,325 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-08-29 |
4 |
AS |
$15.13 |
$75,634 |
D/D |
(5,000) |
9,387 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2018-07-02 |
4 |
OE |
$13.00 |
$78,000 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2018-10-01 |
4 |
OE |
$13.00 |
$78,000 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-09-28 |
4 |
AS |
$16.28 |
$81,423 |
D/D |
(5,000) |
9,387 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-12-28 |
4 |
AS |
$16.97 |
$84,862 |
D/D |
(5,000) |
9,731 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-11-28 |
4 |
AS |
$17.67 |
$88,357 |
D/D |
(5,000) |
9,731 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2012-01-30 |
4 |
AS |
$18.01 |
$90,030 |
D/D |
(5,000) |
9,731 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2015-06-02 |
4 |
OE |
$8.80 |
$92,400 |
D/D |
10,500 |
10,500 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Operations |
• – – |
2009-05-19 |
4 |
OE |
$3.90 |
$97,500 |
D/D |
25,000 |
27,713 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2018-01-10 |
4 |
OE |
$13.00 |
$98,592 |
D/D |
7,584 |
7,584 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2012-02-28 |
4 |
AS |
$20.99 |
$104,971 |
D/D |
(5,000) |
9,731 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2010-10-28 |
4 |
AS |
$21.03 |
$105,144 |
D/D |
(5,000) |
3,700 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-10-28 |
4 |
AS |
$21.27 |
$106,374 |
D/D |
(5,000) |
9,387 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2010-11-29 |
4 |
AS |
$22.24 |
$111,219 |
D/D |
(5,000) |
4,044 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2012-03-28 |
4 |
AS |
$22.65 |
$113,272 |
D/D |
(5,000) |
9,731 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2010-09-28 |
4 |
AS |
$23.03 |
$115,139 |
D/D |
(5,000) |
3,700 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-07-28 |
4 |
AS |
$23.56 |
$117,813 |
D/D |
(5,000) |
9,387 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-05-31 |
4 |
AS |
$24.83 |
$124,172 |
D/D |
(5,000) |
9,387 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-06-28 |
4 |
AS |
$25.37 |
$126,875 |
D/D |
(5,000) |
9,387 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2020-12-22 |
4 |
OE |
$13.00 |
$130,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-02-28 |
4 |
AS |
$26.50 |
$132,483 |
D/D |
(5,000) |
9,044 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2010-12-28 |
4 |
AS |
$26.62 |
$133,076 |
D/D |
(5,000) |
4,044 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-01-28 |
4 |
AS |
$27.38 |
$136,923 |
D/D |
(5,000) |
9,044 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
SVP, Regulatory & Dev Ops |
• – – |
2011-03-28 |
4 |
AS |
$27.76 |
$138,824 |
D/D |
(5,000) |
9,044 |
0 |
- |
|
119 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
